 BioLife Solutions, Inc. NASDAQ: BLFS BioLife or the Company, a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today provided an update on adoption of its evo cold chain management platform solution by cell and gene therapy companies. 